Home › Funds › Point72 Asset Management › AMPH
Point72 Asset Management position in AMPH
AMPHASTAR PHARMACEUTICALS IN · Health Care
Latest position (Q2 2026)54.96K sh
Reported value held$1.11M
Portfolio Weight0.00%
First reportedQ1 2023
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2023 | 65.42K | $2.45M | New |
| Q3 2023 | 1.28K | $59.01K | New |
| Q1 2024 | 262.40K | $11.52M | New |
| Q2 2024 | 235.84K | $9.43M | Reduce |
| Q3 2024 | 38.82K | $1.88M | Reduce |
| Q4 2024 | 9.20K | $341.60K | Reduce |
| Q2 2026 | 54.96K | $1.11M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding AMPH
- Vanguard Group 2.61M sh · $69.85M · Q4 2025
- Marshall Wace 1.07M sh · $21.52M · Q2 2026
- Geode Capital Management 969.84K sh · $19.58M · Q2 2026
- D. E. Shaw & Co 887.05K sh · $17.90M · Q2 2026
- Renaissance Technologies 525.10K sh · $10.60M · Q2 2026
- Goldman Sachs Group 505.36K sh · $10.20M · Q2 2026
- UBS Group AG 393.11K sh · $7.93M · Q2 2026
- Northern Trust Corp 370.99K sh · $7.49M · Q2 2026
- Charles Schwab Investment Management 310.18K sh · $6.26M · Q2 2026
- BlackRock Inc 6.83M sh · $6.19M · Q2 2026
- Royce & Associates 294.76K sh · $5.95M · Q2 2026
- Two Sigma Investments 248.12K sh · $5.01M · Q2 2026